Delta4 receives European patents for two compounds as candidate treatments for focal segmental glomerulosclerosis: Vienna, Austria Monday, February 3, 2025, 18:00 Hrs [IST] Delta4 ...
The future of medicine may very well lie in the personalization of health care—knowing exactly what an individual needs and ...
Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...
Interesting Engineering on MSN4d
New US sweat sensors track health in real-time with printed nanoparticle inkCaltech manufactures wearable sweat sensors equipped with special nanoparticles that inkjet print a biomarker, ...
The future of medicine may very well lie in the personalization of health care-knowing exactly what an individual needs and then delivering just the ...
Caltech engineers have developed a technique that enables the mass production of sweat sensors to monitor biomarkers.
The future of medicine may very well lie in the personalization of health care—knowing exactly what an individual needs and then delivering just the ...
Rituximab, a monoclonal antibody directed against the CD20 molecule found on pre-B cells ... complete remission (normalization of serum creatinine and serum albumin, inactive urinary sediment ...
AZoSensors on MSN3d
Wearable Sweat Sensors Made with Inkjet PrintingCaltech engineers have developed inkjet-printed core-shell nanoparticles for durable wearable sweat sensors, enabling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback